TABLE 1.
Comparisons of anthropometric values, insulin sensitivity measures and metabolites, at baseline and follow‐up
| Baseline Mean (SE), n = 33 | Follow‐up Mean (SE), n = 33 | p‐value | |
|---|---|---|---|
| Anthropometric values | |||
| Age, years | 14.20 (0.25) | 14.71 (0.25) | <.0001 |
| BMI | 34.67 (1.17) | 34.85 (1.21) | .5108 |
| BMI % | 98.31 (0.29) | 98.27 (0.24) | .8025 |
| BMI Z‐score | 2.27 (0.07) | 2.25 (0.07) | .3586 |
| BMI% exceeding the 95th percentile | 129.75 (4.14) | 128.30 (4.24) | .1674 |
| % BF | 41.21 (1.49) | 41.88 (1.62) | .7147 |
| Systolic BP, mmHg | 120.30 (2.08) | 115.82 (1.71) | .0385 |
| Diastolic BP, mmHg | 64.73 (1.66) | 64.65 (1.39) | .9523 |
| Insulin sensitivity measures | |||
| Adiponectin, μg/ml | 15.90 (1.28) | 16.31 (1.20) | .6026 |
| HOMA‐IR | 4.04 (0.62) | 5.20 (1.29) | .1310 |
| TG to HDL ratio | 1.85 (0.22) | 1.89 (0.26) | .7800 |
| Metabolites | |||
| Glutamate/glutamine μM | 35.17 (2.06) | 34.08 (1.53) | .4529 |
| Valine, μM | 118.27 (3.37) | 116.76 (3.91) | .7193 |
| Leucine/Isoleucine, μM | 84.31 (2.28) | 84.39 (2.63) | .9731 |
| BCAA, μM | 202.58 (5.38) | 201.15 (6.33) | .8219 |
| C2 acylcarnitine, μM | 3.37 (0.25) | 2.84 (0.18) | .0148 |
| C3 acylcarnitine, μM | 0.16 (0.01) | 0.15 (0.01) | .8472 |
| C5 acylcarnitine, μM | 0.07 (0.01) | 0.07 (0.01) | .9574 |